SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1qxp'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_B_CCSB381_0
(ESTROGEN RECEPTOR)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		3 / 3 GLU A 885
ALA A   5
SER A 870
 None
 0.56A 1errB-1qxpA:
0.0		 1errB-1qxpA:
14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 10 LEU A 181
ALA A 203
ILE A 340
GLY A 210
GLY A 209
 None
 1.05A 1k6cA-1qxpA:
undetectable		 1k6cA-1qxpA:
7.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M4D_B_TOYB501_1
(AMINOGLYCOSIDE
2'-N-ACETYLTRANSFERA
SE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 9 ASP A 777
ALA A 371
ASP A 497
THR A 364
ASP A 779
 None
 1.41A 1m4dB-1qxpA:
0.0		 1m4dB-1qxpA:
11.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NW5_A_SAMA401_0
(MODIFICATION
METHYLASE RSRI)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 12 THR A 336
GLY A 239
VAL A 266
ALA A 110
ALA A 109
 None
 1.02A 1nw5A-1qxpA:
undetectable		 1nw5A-1qxpA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOQ_A_ROFA502_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		3 / 3 ASN A 384
TRP A 365
GLN A 386
 None
 1.23A 1xoqA-1qxpA:
undetectable		 1xoqA-1qxpA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HC4_A_VDXA525_2
(VITAMIN D RECEPTOR)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 LEU A 410
LEU A 411
ILE A 431
SER A 488
 None
 0.95A 2hc4A-1qxpA:
0.0		 2hc4A-1qxpA:
16.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2TSR_B_D16B409_1
(THYMIDYLATE SYNTHASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 8 ILE A  73
TRP A  75
LEU A  63
GLY A  59
 None
 0.96A 2tsrB-1qxpA:
undetectable		 2tsrB-1qxpA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XH9_A_J01A1437_1
(ORF12)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 11 SER A 778
TYR A 791
ALA A   2
GLY A   3
ALA A   5
 None
 1.43A 2xh9A-1qxpA:
0.0		 2xh9A-1qxpA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XH9_B_J01B1437_1
(ORF12)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 10 SER A 778
TYR A 791
ALA A   2
GLY A   3
ALA A   5
 None
 1.39A 2xh9B-1qxpA:
0.0		 2xh9B-1qxpA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 PHE A 503
GLU A 339
SER A 236
ARG A 501
 None
 1.36A 3dqtA-1qxpA:
undetectable
3dqtB-1qxpA:
undetectable		 3dqtA-1qxpA:
19.53
3dqtB-1qxpA:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_C_TOPC200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 11 ALA A 412
GLU A 471
VAL A 211
LEU A 343
PHE A 503
 None
 1.27A 3fl9C-1qxpA:
undetectable		 3fl9C-1qxpA:
9.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_D_TOPD200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 9 ALA A 412
GLU A 471
VAL A 211
LEU A 343
PHE A 503
 None
 1.21A 3fl9D-1qxpA:
undetectable		 3fl9D-1qxpA:
9.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB1_A_SAMA1101_0
(STRUCTURAL PROTEIN
VP3)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 12 ILE A 138
ALA A 184
ASP A  48
PRO A  49
ALA A  50
 None
 1.08A 3jb1A-1qxpA:
undetectable		 3jb1A-1qxpA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MBG_A_ACTA207_0
(FAD-LINKED
SULFHYDRYL OXIDASE
ALR)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 GLU A 495
ARG A 366
THR A 780
ALA A 650
 None
 1.32A 3mbgA-1qxpA:
0.0
3mbgB-1qxpA:
0.0		 3mbgA-1qxpA:
9.44
3mbgB-1qxpA:
9.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5T_A_H4BA600_1
(NITRIC OXIDE
SYNTHASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 SER A 236
ARG A 501
PHE A 503
GLU A 339
 None
 1.46A 3n5tA-1qxpA:
undetectable
3n5tB-1qxpA:
undetectable		 3n5tA-1qxpA:
20.27
3n5tB-1qxpA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3S_F_9PLF1_1
(CYTOCHROME P450 2A13)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 8 PHE A  87
PHE A 131
PHE A 141
ALA A 179
 None
 1.00A 3t3sF-1qxpA:
undetectable		 3t3sF-1qxpA:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_B_W9TB502_1
(HEMOLYTIC LECTIN
CEL-III)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 GLY A 103
LEU A  63
TYR A 192
GLU A 182
 None
 0.98A 3w9tB-1qxpA:
undetectable		 3w9tB-1qxpA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_E_W9TE502_1
(HEMOLYTIC LECTIN
CEL-III)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 GLY A 103
LEU A  63
TYR A 192
GLU A 182
 None
 0.97A 3w9tE-1qxpA:
undetectable		 3w9tE-1qxpA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_F_W9TF503_1
(HEMOLYTIC LECTIN
CEL-III)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 GLY A 103
LEU A  63
TYR A 192
GLU A 182
 None
 0.97A 3w9tF-1qxpA:
undetectable		 3w9tF-1qxpA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX7_C_H4BC600_1
(NITRIC OXIDE
SYNTHASE, INDUCIBLE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 8 SER A 236
ARG A 501
PHE A 503
GLU A 339
 None
 1.20A 4cx7C-1qxpA:
0.0
4cx7D-1qxpA:
0.0		 4cx7C-1qxpA:
19.31
4cx7D-1qxpA:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5J_B_H4BB502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 PHE A 503
GLU A 339
SER A 236
ARG A 501
 None
 1.38A 4k5jA-1qxpA:
undetectable
4k5jB-1qxpA:
undetectable		 4k5jA-1qxpA:
20.47
4k5jB-1qxpA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YGF_A_AZMA303_1
(ALPHA-CARBONIC
ANHYDRASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 11 VAL A 124
VAL A 125
LEU A 114
ALA A 110
TRP A 177
 None
 1.39A 4ygfA-1qxpA:
undetectable		 4ygfA-1qxpA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YGF_C_AZMC303_1
(ALPHA-CARBONIC
ANHYDRASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 11 VAL A 124
VAL A 125
LEU A 114
ALA A 110
TRP A 177
 None
 1.44A 4ygfC-1qxpA:
undetectable		 4ygfC-1qxpA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YHA_A_MZMA303_1
(ALPHA-CARBONIC
ANHYDRASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 12 VAL A 124
VAL A 125
LEU A 114
ALA A 110
TRP A 177
 None
 1.33A 4yhaA-1qxpA:
undetectable		 4yhaA-1qxpA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZME_B_ADNB902_1
(MYOSIN HEAVY CHAIN
KINASE A)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 10 PHE A 381
VAL A 486
LEU A 513
LEU A 449
PHE A 453
 None
 1.30A 4zmeB-1qxpA:
undetectable		 4zmeB-1qxpA:
15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZC_E_ACTE406_0
(PROTON-GATED ION
CHANNEL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 5 ILE A 689
ILE A 879
ARG A  12
GLU A 885
 None
 0.95A 4zzcE-1qxpA:
undetectable		 4zzcE-1qxpA:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADL_B_H4BB600_1
(ENDOTHELIAL NITRIC
OXIDE SYNTHASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 PHE A 503
GLU A 339
SER A 236
ARG A 501
 None
 1.35A 5adlA-1qxpA:
undetectable
5adlB-1qxpA:
undetectable		 5adlA-1qxpA:
20.47
5adlB-1qxpA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTI_E_LFXE101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 5 SER A 113
ARG A 283
GLY A 322
GLU A 323
 None
 1.18A 5btiA-1qxpA:
0.0
5btiB-1qxpA:
undetectable		 5btiA-1qxpA:
20.81
5btiB-1qxpA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTI_F_LFXF101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 5 SER A 113
ARG A 283
GLY A 322
GLU A 323
 None
 1.16A 5btiC-1qxpA:
undetectable
5btiD-1qxpA:
undetectable		 5btiC-1qxpA:
20.81
5btiD-1qxpA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 ALA A 371
THR A 370
VAL A 383
VAL A 649
 None
 0.77A 5eckA-1qxpA:
undetectable		 5eckA-1qxpA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 ALA A 371
THR A 370
VAL A 383
VAL A 649
 None
 0.82A 5eckD-1qxpA:
undetectable		 5eckD-1qxpA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 ALA A 371
THR A 370
VAL A 383
VAL A 649
 None
 0.75A 5eclA-1qxpA:
undetectable		 5eclA-1qxpA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 ALA A 371
THR A 370
VAL A 383
VAL A 649
 None
 0.86A 5eclD-1qxpA:
0.0		 5eclD-1qxpA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECN_D_LEUD602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 8 ALA A 371
THR A 370
VAL A 383
VAL A 649
 None
 0.77A 5ecnD-1qxpA:
undetectable		 5ecnD-1qxpA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FJ3_B_H4BB600_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 PHE A 503
GLU A 339
SER A 236
ARG A 501
 None
 1.40A 5fj3A-1qxpA:
undetectable
5fj3B-1qxpA:
undetectable		 5fj3A-1qxpA:
20.47
5fj3B-1qxpA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KGJ_A_X6XA402_1
(PREDICTED
ACETYLTRANSFERASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 5 ARG A 501
GLU A 471
ASP A 206
TRP A 144
 None
 1.34A 5kgjA-1qxpA:
0.0		 5kgjA-1qxpA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LJE_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 12 LEU A 478
ALA A 461
LEU A 449
PHE A 433
ILE A 389
 None
 0.96A 5ljeA-1qxpA:
undetectable		 5ljeA-1qxpA:
9.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TT3_G_EZLG303_1
(ALPHA-CARBONIC
ANHYDRASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 9 VAL A 124
VAL A 125
LEU A 114
ALA A 110
TRP A 177
 None
 1.46A 5tt3G-1qxpA:
undetectable		 5tt3G-1qxpA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO8_A_H4BA502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 SER A 236
ARG A 501
PHE A 503
GLU A 339
 None
 1.45A 5uo8A-1qxpA:
0.0
5uo8B-1qxpA:
0.0		 5uo8A-1qxpA:
20.13
5uo8B-1qxpA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV7_B_H4BB502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 PHE A 503
GLU A 339
SER A 236
ARG A 501
 None
 1.41A 5vv7A-1qxpA:
undetectable
5vv7B-1qxpA:
undetectable		 5vv7A-1qxpA:
20.47
5vv7B-1qxpA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV6_B_H4BB501_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 SER A 236
ARG A 501
PHE A 503
GLU A 339
 None
 1.39A 6av6A-1qxpA:
undetectable
6av6B-1qxpA:
undetectable		 6av6A-1qxpA:
7.35
6av6B-1qxpA:
7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV7_A_H4BA502_1
(NITRIC OXIDE
SYNTHASE,
ENDOTHELIAL)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 7 SER A 236
ARG A 501
PHE A 503
GLU A 339
 None
 1.39A 6av7A-1qxpA:
0.0
6av7B-1qxpA:
undetectable		 6av7A-1qxpA:
7.35
6av7B-1qxpA:
7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C06_D_FI8D1404_1
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA')		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		3 / 3 ARG A 390
LYS A 388
ARG A 630
 None
 1.29A 6c06D-1qxpA:
undetectable		 6c06D-1qxpA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EFN_A_SAMA501_0
(SPORULATION KILLING
FACTOR MATURATION
PROTEIN SKFB)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 11 THR A 208
PHE A 204
SER A 113
THR A 267
LEU A 232
 None
 1.33A 6efnA-1qxpA:
undetectable		 6efnA-1qxpA:
18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F8C_A_STRA502_1
(CYTOCHROME P450
CYP260A1)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		4 / 6 ALA A 231
GLY A 210
THR A 208
ILE A 120
 None
 0.70A 6f8cA-1qxpA:
undetectable		 6f8cA-1qxpA:
6.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_B_QPSB601_3
(-)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		3 / 3 ASP A 655
ASP A 660
ASN A 560
 None
 0.85A 6gngB-1qxpA:
undetectable		 6gngB-1qxpA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6QXS_B_FOZB403_0
(THYMIDYLATE SYNTHASE)		 1qxp MU-LIKE CALPAIN
(Bos
taurus;
Rattus
norvegicus) 		5 / 12 LEU A 348
TRP A 356
LEU A 410
GLY A 209
ILE A 340
 None
 1.09A 6qxsB-1qxpA:
undetectable		 6qxsB-1qxpA:
17.12